Suppr超能文献

基于微流控孔的 DNA 生物测定法,用于使用 MNAzymes 进行多重核酸检测,具有单碱基分辨率。

DNA-only, microwell-based bioassay for multiplex nucleic acid detection with single base-pair resolution using MNAzymes.

机构信息

Department of Biosystems, Biosensors Group, KU Leuven, 3001, Leuven, Belgium.

VIB-KU Leuven Center for Brain & Disease Research, KU Leuven, 3000, Leuven, Belgium.

出版信息

Biosens Bioelectron. 2020 Mar 15;152:112017. doi: 10.1016/j.bios.2020.112017. Epub 2020 Jan 10.

Abstract

In disease diagnostics, single- and multiplex nucleic acid (NA) detection, with the potential to discriminate mutated strands, is of paramount importance. Current techniques that rely on target amplification or protein-enzyme based signal amplification are highly relevant, yet still plagued by diverse drawbacks including erroneous target amplification, and the limited stability of protein enzymes. As a solution, we present a multicomponent nucleic acid enzymes (MNAzymes)-based system for singleplex and multiplex detection of NA targets in microwells down to femtomolar (fM) concentrations, without the need for any target amplification or protein enzymes, while operating at room temperature and with single base-pair resolution. After successful validation of the MNAzymes in solution, their performance was further verified on beads in bulk and in femtoliter-sized microwells. The latter is not only a highly simplified system compared to previous microwell-based bioassays but, with the detection limit of 180 fM, it is to-date the most sensitive NAzyme-mediated, bead-based approach, that does not rely on target amplification or any additional signal amplification strategies. Furthermore, we demonstrated, for the first time, multiplexed target detection in microwells, both from buffer and nasopharyngeal swab samples, and presented superior single base-pair resolution of this assay. Because of the design flexibility of MNAzymes and direct demonstration in swab samples, this system holds great promise for multiplexed detection in other clinically relevant matrices without the need for any additional NA or protein components. Moreover, these findings open up the potential for the development of next-generation, protein-free diagnostic tools, including digital assays with single-molecule resolution.

摘要

在疾病诊断中,能够区分突变链的单重和多重核酸(NA)检测至关重要。目前基于目标扩增或基于蛋白质-酶的信号扩增的技术具有重要意义,但仍然存在多种缺点,包括错误的目标扩增和蛋白质酶的稳定性有限。作为一种解决方案,我们提出了一种基于多组分核酸酶(MNAzymes)的系统,用于在微井中进行单重和多重 NA 靶标检测,检测下限低至飞摩尔(fM)浓度,无需任何靶标扩增或蛋白质酶,并且在室温下操作,具有单碱基对分辨率。在溶液中成功验证了 MNAzymes 后,进一步在大量珠子和飞升尺寸的微井中验证了它们的性能。与以前基于微井的生物测定相比,后者不仅是一个高度简化的系统,但检测限为 180 fM,是迄今为止最灵敏的不依赖于目标扩增或任何额外信号扩增策略的基于 MNAzymes 的珠基方法。此外,我们首次在微井中进行了缓冲液和鼻咽拭子样本的多重目标检测,并展示了该测定法具有卓越的单碱基对分辨率。由于 MNAzymes 的设计灵活性以及在拭子样本中的直接证明,该系统具有在其他临床相关基质中进行多重检测的巨大潜力,而无需任何额外的 NA 或蛋白质成分。此外,这些发现为开发下一代无蛋白质的诊断工具开辟了可能性,包括具有单分子分辨率的数字测定法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验